Skip to main content
FinSpry Logo
FinSpry
OCS logo
OCS
(NASDAQ)
Oculis Holding AG
$12.17-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Oculis Holding (OCS) Stock Price & Financial Analysis

Oculis Holding Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.93 - $12.66
52-Week High$34.48
52-Week Low$10.52
Open$12.07
Volume123.28K
Average Volume (3M)230.48K
Market Cap716.88M
Shares Outstanding58.91M
Price to Sales (P/S)1151.66
Price to Book (P/B)2.96
EV/EBITDA-5.78
Revenue (TTM)622.48K
Net Income (TTM)-117.41M
Free Cash Flow (TTM)-77.16M
EPS (TTM)$-2.14
Profit Margin-18861.29%
Operating Margin-16740.95%
Return on Equity (ROE)-48.49%
Debt to Equity0.01
50-Day MA$12.56
200-Day MA$21.04
52-Week Change-29.33%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Oculis Holding

What is the current stock price for OCS?

As of the latest trading session, OCS stock trades at $12.17. The 52-week range is $10.52–$34.48, with a day range of $11.93–$12.66.

What is the P/E ratio for OCS?

The P/E ratio (Price-to-Earnings) for OCS is shown in the Key Statistics section. This valuation metric helps compare Oculis Holding AG to industry peers.

Does OCS pay dividends?

Oculis Holding does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OCS?

Based on 1 analyst, the consensus for OCS is Buy.

What is the market cap of OCS?

Oculis Holding's market capitalization is $716.9M, classifying it as a small-cap company. Oculis Holding operates in the Healthcare sector within the Biotechnology industry.